• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过整合肠道微生物群测序、代谢组学和蛋白质组学分析SARS-CoV-2抗性人群的生物学特征:一项队列比较研究

Biological characteristics of SARS-CoV-2 resistant populations by integrated gut microbiota sequencing, metabolomics, and proteomics: a cohort comparison study.

作者信息

Xu Huachong, Li Haoxuan, Xu Junhao, Chen Yaoxin, Deng Li, Chen Xiaoyin, Xu Yinji

机构信息

School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China.

Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, Guangdong, China.

出版信息

Front Med (Lausanne). 2025 Jul 7;12:1593007. doi: 10.3389/fmed.2025.1593007. eCollection 2025.

DOI:10.3389/fmed.2025.1593007
PMID:40692947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277166/
Abstract

OBJECTIVE

Most research reports on COVID-19 infections have focused on the correlation between the severity of the disease symptoms and immune deficits, while the mechanisms affecting the susceptibility to SARS-CoV-2 remain largely unknown. The study aimed to comprehensively analyze the differences in immunity, gut microbiota, metabolism, and proteomics between the SARS-CoV-2 resistant population and the susceptible population.

METHODS AND RESULTS

In this cohort comparison study, participants were rigorously selected based on inclusion and exclusion criteria in a continuous enrollment manner using combined questionnaires and clinical data, ultimately including 25 SARS-CoV-2 resistant volunteers versus 16 SARS-CoV-2 infected patients. The clinical information of the participants was recorded in detail, and fecal and blood samples were collected in a standardized manner for subsequent multi-omics analysis, including gut microbiota sequencing, metabolomics, and proteomics. This study has preliminarily elucidated the characteristics of the gut microbiota, serum metabolites, and serum proteins in the SARS-CoV-2 resistant population. It exhibits a unique metabolic signature characterized by elevated levels of serum phosphatidylinositol and the abundance of Prevotella, which may serve as a potential predictive biomarker for resistance to SARS-CoV-2.

CONCLUSION

Given the crucial role of phosphatidylinositol in cell membrane architecture and viral infectivity, this study provides a promising entry point for further research into the pathogenesis and prevention strategies of COVID-19.

摘要

目的

大多数关于新冠病毒感染的研究报告都集中在疾病症状严重程度与免疫缺陷之间的相关性上,而影响对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)易感性的机制在很大程度上仍不清楚。本研究旨在全面分析SARS-CoV-2抗性人群和易感人群在免疫、肠道微生物群、代谢和蛋白质组学方面的差异。

方法与结果

在这项队列比较研究中,根据纳入和排除标准,采用联合问卷和临床数据以连续入组的方式严格筛选参与者,最终纳入25名SARS-CoV-2抗性志愿者和16名SARS-CoV-2感染患者。详细记录参与者的临床信息,并以标准化方式收集粪便和血液样本,用于后续的多组学分析,包括肠道微生物群测序、代谢组学和蛋白质组学。本研究初步阐明了SARS-CoV-2抗性人群的肠道微生物群、血清代谢物和血清蛋白的特征。它表现出一种独特的代谢特征,其特点是血清磷脂酰肌醇水平升高和普雷沃氏菌丰度增加,这可能作为对SARS-CoV-2抗性的潜在预测生物标志物。

结论

鉴于磷脂酰肌醇在细胞膜结构和病毒感染性中的关键作用,本研究为进一步研究新冠病毒的发病机制和预防策略提供了一个有前景的切入点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/40c559d4c17b/fmed-12-1593007-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/c80eb55c8161/fmed-12-1593007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/2e8ac1738662/fmed-12-1593007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/016f2f6dcacd/fmed-12-1593007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/6cc4555050a9/fmed-12-1593007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/efecb439add2/fmed-12-1593007-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/40c559d4c17b/fmed-12-1593007-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/c80eb55c8161/fmed-12-1593007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/2e8ac1738662/fmed-12-1593007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/016f2f6dcacd/fmed-12-1593007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/6cc4555050a9/fmed-12-1593007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/efecb439add2/fmed-12-1593007-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5a/12277166/40c559d4c17b/fmed-12-1593007-g006.jpg

相似文献

1
Biological characteristics of SARS-CoV-2 resistant populations by integrated gut microbiota sequencing, metabolomics, and proteomics: a cohort comparison study.通过整合肠道微生物群测序、代谢组学和蛋白质组学分析SARS-CoV-2抗性人群的生物学特征:一项队列比较研究
Front Med (Lausanne). 2025 Jul 7;12:1593007. doi: 10.3389/fmed.2025.1593007. eCollection 2025.
2
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
3
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
6
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
7
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
8
[Effect mechanism of electroacupuncture on diabetic peripheral neuropathy in rats based on gut microbiota and metabolomics].基于肠道菌群和代谢组学探讨电针对大鼠糖尿病周围神经病变的作用机制
Zhongguo Zhen Jiu. 2025 Jul 12;45(7):945-956. doi: 10.13703/j.0255-2930.20250225-k0005. Epub 2025 May 12.
9
Laboratory-based molecular test alternatives to RT-PCR for the diagnosis of SARS-CoV-2 infection.基于实验室的分子检测替代 RT-PCR 用于 SARS-CoV-2 感染的诊断。
Cochrane Database Syst Rev. 2024 Oct 14;10(10):CD015618. doi: 10.1002/14651858.CD015618.
10
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.奈玛特韦片/利托那韦片组合包装用于 COVID-19 的预防和治疗。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD015395. doi: 10.1002/14651858.CD015395.pub2.

本文引用的文献

1
Relationship Between the Gut Microbiome, Tryptophan-Derived Metabolites, and Osteoarthritis-Related Pain: A Systematic Review with Meta-Analysis.肠道微生物群、色氨酸衍生代谢物与骨关节炎相关疼痛之间的关系:一项荟萃分析的系统评价
Nutrients. 2025 Jan 12;17(2):264. doi: 10.3390/nu17020264.
2
Effectiveness of telerehabilitation versus face-to-face pulmonary rehabilitation on physical function and quality of life in people with post COVID-19 condition: a systematic review and network meta-analysis.远程康复与面对面肺康复对新冠后人群身体功能和生活质量的有效性:系统评价和网络荟萃分析。
Eur J Phys Rehabil Med. 2024 Oct;60(5):868-877. doi: 10.23736/S1973-9087.24.08540-X. Epub 2024 Sep 5.
3
The pulmonary rehabilitation effect on long covid-19 syndrome: A systematic review and meta-analysis.
肺康复对长新冠综合征的疗效:系统评价和荟萃分析。
Physiother Res Int. 2024 Apr;29(2):e2077. doi: 10.1002/pri.2077.
4
Estimating the heritability of SARS-CoV-2 susceptibility and COVID-19 severity.估算 SARS-CoV-2 易感性和 COVID-19 严重程度的遗传力。
Nat Commun. 2024 Jan 8;15(1):367. doi: 10.1038/s41467-023-44250-7.
5
Temporal changes in fecal microbiota of patients infected with COVID-19: a longitudinal cohort.新冠病毒感染患者粪便微生物群的时间变化:一项纵向队列研究。
BMC Infect Dis. 2023 Aug 18;23(1):537. doi: 10.1186/s12879-023-08511-6.
6
Deficiency in the production of antibodies to lipids correlates with increased lipid metabolism in severe COVID-19 patients.严重 COVID-19 患者体内产生针对脂质的抗体不足与脂质代谢增加相关。
Front Immunol. 2023 Jun 23;14:1188786. doi: 10.3389/fimmu.2023.1188786. eCollection 2023.
7
Altered infective competence of the human gut microbiome in COVID-19.COVID-19 中人类肠道微生物组感染能力的改变。
Microbiome. 2023 Mar 9;11(1):46. doi: 10.1186/s40168-023-01472-7.
8
Gut microbiome and anti-viral immunity in COVID-19.肠道微生物组与 COVID-19 的抗病毒免疫。
Crit Rev Food Sci Nutr. 2024;64(14):4587-4602. doi: 10.1080/10408398.2022.2143476. Epub 2022 Nov 16.
9
Multicomponent Exercise Program to Improve the Immediate Sequelae of COVID-19: A Prospective Study with a Brief Report of 2-Year Follow-Up.多组分运动方案改善 COVID-19 即刻后遗症:一项前瞻性研究及 2 年随访的简要报告。
Int J Environ Res Public Health. 2022 Sep 29;19(19):12396. doi: 10.3390/ijerph191912396.
10
Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19.COVID-19 中神经鞘脂和甘油磷脂的动态调节。
Clin Transl Med. 2022 Oct;12(10):e1069. doi: 10.1002/ctm2.1069.